This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Joseph McKenna: Innovator in Biaryl Derivatives
Introduction
Joseph McKenna is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit protein-protein interactions.
Latest Patents
McKenna holds a patent for "Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors." This invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, showcasing his innovative approach to addressing complex biological interactions.
Career Highlights
Joseph McKenna is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on groundbreaking research and development in the pharmaceutical industry.
Collaborations
He has collaborated with talented coworkers, including Vincent Bordas and Cara Brocklehurst, to advance his research and contribute to the scientific community.
Conclusion
Joseph McKenna's work in biaryl derivatives exemplifies the innovative spirit of modern inventors. His contributions to the field of pharmaceuticals continue to impact the development of new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile